🔥Telegram İfşa

🌟 Exciting news! 🌟 🎙️ Our podcast series Visionary Voices is now on Spotify! 🎙️ Join us and our incredible guests as we explore key trends, innovations and the stories shaping the pharmaceutical and healthcare industries. 🎧 Ready to tune in? Click below to explore our

🧠 Rheumatoid Arthritis and Cognitive Health A new study highlights that patients with rheumatoid arthritis (RA) face a higher risk of cognitive impairment, particularly in memory, visuospatial-executive function, and abstraction. The risk appears closely linked to inflammation

⭐ Future Leaders in Focus ⭐ We’re proud to feature Dr. Sham Santhanam in our Future Leaders series – celebrating the rising stars of medicine! A passionate voice in rheumatology, Dr. Santhanam shares his journey, achievements, and vision for advancing care through innovation,

Age-related diseases affect millions worldwide — could senolytics offer a new approach to treatment? In this episode of Visionary Voices, Nicky speaks with Prof. Georgina Ellison-Hughes from King’s College London about the groundbreaking field of senolytics and their potential

📢 Managing Sjögren Disease in Young People – Key Challenges Sjögren disease (SjD) in children and adolescents is rare and often under-recognised. Clinical presentations in young people differ from adults, making diagnosis and management challenging. This review discusses

💡 Transforming IBD Care with Precision Medicine – Q&A with Future Leader Dr Bram Verstockt In this exclusive interview, Dr Bram Verstockt shares how his translational research is driving change in IBD care – from non-invasive monitoring tools like intestinal ultrasound to

As immune checkpoint inhibitors (ICIs) transform cancer care, immune-related adverse events like inflammatory arthritis are on the rise. 🧬 This expert editorial outlines how clinicians can recognise, assess, and manage ICI-induced arthritis (ICI-IA)—bridging gaps between

Calling all rheumatology & muskoskeletal healthcare professionals! Submit your research to touchREVIEWS in RMD & reach a global audience! Peer-reviewed, diverse content, practical impact.🌍✍️ Learn more & submit: touchimmunology.com/journal-articl… #CallforPapers #CallforSubmissions #MedEd

We’ve captured the key moments from ACR Convergence 2025!🧬 From late-breaking clinical data, emerging therapies, and real-world clinical applications, our coverage brings together the most important takeaways from the conference. Whether you’re in research, clinical practice,

🔬 Bridging Bench & Bedside in Rheumatology Dr Sonali Bracken (Duke University) shares her insights as a physician-scientist shaping the future of autoimmune care. From the role of B cells in fibrosis to the promise of cellular therapies, her work brings research closer to real

🌟 Rising Star: Dr. Hassan Abushukair 🌟 Meet Dr. Hassan Abushukair, a rising star in immuno-oncology and precision medicine. As part of our Future Leaders feature, we had the honour of speaking with him about his career journey, groundbreaking research, and aspirations in

In case you missed it: our ACR Convergence 2025 coverage is packed with insights for rheumatologists!🧬 From late-breaking clinical data, emerging therapies, and real-world clinical applications, our roundup highlights the key developments from the conference. All our Q&As and

The ASAS–SPARTAN 2025 Classification Criteria are here — improving specificity and sensitivity in diagnosing axSpA. In our latest Q&A, Dr Walter Maksymowych discusses the rationale for revising the 2009 criteria, how SpA variables were selected and weighted, and the performance

💊 Glucocorticoids in Early RA: A new study from the Canadian Early Arthritis Cohort (CATCH) compares parenteral vs. oral glucocorticoids and their impact on steroid-free status at 12 months. Dr Janet Pope explores the findings and what they mean for minimizing GC exposure in

Explore what’s next for rheumatology, from novel therapies, emerging research, and evolving diagnostics. In this interview, Dr Nancy Lane shares her personal highlights from #ACR2025. 👉 Read the full interview: touchimmunology.com/insight/rheuma… #Rheumatology #Lupus #Osteoarthritis

Juvenile Idiopathic Arthritis or Growing Pains: Catching Arthritis Early Joint pain in childhood is common, but chronic symptoms may signal juvenile idiopathic arthritis (JIA), the most frequent paediatric rheumatic disease. Early diagnosis and treatment can improve long-term

💡Therapeutic Virtual Reality in Rheumatology: A Narrative Review Chronic pain, fatigue, and fear of movement remain major challenges in rheumatology. Therapeutic virtual reality (VR) offers an immersive, interactive, and personalised approach to support self-management, deliver

What’s next for osteoarthritis research? 🦴 We spoke with Dr Tom Appleton (St. Joseph’s Health Care London / Western University, Canada) about his dual role as clinician and scientist, and how his work is advancing our understanding of OA. Key insights from Dr Appleton:

📢 We’re proud to spotlight Dr Andreas Hadjinicolaou, a clinician-scientist at the University of Cambridge and a 2025 touchIMMUNOLOGY Future Leader. In this insightful Q&A, Dr Hadjinicolaou shares how his dual roles in clinical care and research are driving innovation in early

🧬 What can imaging teach us about liver immunity? In this exclusive Q&A, Dr Moritz Peiseler, specialist in internal medicine and group leader at Charité University Medicine, shares how intravital microscopy, AI, and spatial omics are helping to map the immune landscape of the